葛兰旗下基金增聘基金经理 多基金经理共管已成行业趋势

Core Viewpoint - The trend of "co-managed fund appointments" is gaining momentum in the industry, with a significant number of funds adopting this model to enhance research and investment capabilities [5][6]. Company Summary - On July 4, 2025, China Europe Medical Health announced the appointment of Zhao Lei as a co-manager alongside Guo Lan for their fund, which has a management scale of 31.179 billion yuan, making it the largest fund managed by Guo Lan [3]. - Zhao Lei, despite lacking prior public fund management experience, has over 8 years of research experience in the pharmaceutical and biotechnology sectors and has held key positions in the industry [3]. - Guo Lan continues to manage two other funds, China Europe Medical Innovation and China Europe Mingrui New Starting Point, with management scales of 8.199 billion yuan and 1.069 billion yuan, respectively [4]. Industry Summary - In the first half of 2025, a total of 1,927 products experienced changes in fund manager appointments, with 666 of these being "co-managed appointments," involving 122 fund companies [5]. - The shift towards team-based management is a significant transformation in the public fund industry, supported by regulatory guidance aimed at enhancing research and investment capabilities [5]. - Over the past year, 29 products under China Europe Fund have implemented "co-managed appointments," reflecting the company's commitment to strengthening its research and investment team [6].